198 related articles for article (PubMed ID: 15842653)
1. Pregnancy and its management in the Philadelphia negative myeloproliferative diseases.
Harrison C
Br J Haematol; 2005 May; 129(3):293-306. PubMed ID: 15842653
[TBL] [Abstract][Full Text] [Related]
2. Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.
Pikman Y; Levine RL
Curr Opin Oncol; 2007 Nov; 19(6):628-34. PubMed ID: 17906464
[TBL] [Abstract][Full Text] [Related]
3. Essential thrombocythemia/polycythemia vera and pregnancy: the need for an observational study in Europe.
Griesshammer M; Struve S; Harrison CM
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):422-9. PubMed ID: 16810618
[TBL] [Abstract][Full Text] [Related]
4. [Management strategy for BCR-ABL negative myeloproliferative neoplasms].
Gotoh A; Komatsu N
Rinsho Ketsueki; 2014 Jan; 55(1):56-65. PubMed ID: 24492037
[No Abstract] [Full Text] [Related]
5. Trends in the incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the city of Göteborg, Sweden, during 1983-99.
Johansson P; Kutti J; Andréasson B; Safai-Kutti S; Vilén L; Wedel H; Ridell B
J Intern Med; 2004 Aug; 256(2):161-5. PubMed ID: 15257729
[TBL] [Abstract][Full Text] [Related]
6. The management of elderly patients with myeloproliferative disorders.
Tura S
Hematol Oncol; 1993; 11 Suppl 1():39-41. PubMed ID: 8486340
[No Abstract] [Full Text] [Related]
7. Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V>F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms.
Najfeld V; Cozza A; Berkofsy-Fessler W; Prchal J; Scalise A
Exp Hematol; 2007 Nov; 35(11):1668-76. PubMed ID: 17976519
[TBL] [Abstract][Full Text] [Related]
8. The myelodysplastic syndromes and myeloproliferative disorders.
Williams JL
Clin Lab Sci; 2004; 17(4):223-34. PubMed ID: 15559729
[TBL] [Abstract][Full Text] [Related]
9. [The treatment of myeloproliferative syndromes].
Maurice P
Schweiz Med Wochenschr; 1975 Oct; 105(40):1269-74. PubMed ID: 1061995
[TBL] [Abstract][Full Text] [Related]
10. Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy.
Griesshammer M; Struve S; Barbui T
Blood Rev; 2008 Sep; 22(5):235-45. PubMed ID: 18617299
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of myeloproliferative neoplasms].
Motoji T
Rinsho Ketsueki; 2010 Oct; 51(10):1428-36. PubMed ID: 20962476
[No Abstract] [Full Text] [Related]
12. Myeloproliferative Neoplasms.
Spivak JL
N Engl J Med; 2017 Jun; 376(22):2168-2181. PubMed ID: 28564565
[No Abstract] [Full Text] [Related]
13. Treatment of essential thrombocythemia during pregnancy with interferon-alpha.
Delage R; Demers C; Cantin G; Roy J
Obstet Gynecol; 1996 May; 87(5 Pt 2):814-7. PubMed ID: 8677098
[TBL] [Abstract][Full Text] [Related]
14. The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders.
Larsen TS; Christensen JH; Hasselbalch HC; Pallisgaard N
Br J Haematol; 2007 Mar; 136(5):745-51. PubMed ID: 17313377
[TBL] [Abstract][Full Text] [Related]
15. Calreticulin: a new horizon for the testing and treatment of myeloproliferative neoplasms.
Guglielmelli P; Bartalucci N; Rotunno G; Vannucchi AM
Expert Rev Hematol; 2014 Aug; 7(4):423-5. PubMed ID: 24849893
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases.
Guilpain P; Montani D; Damaj G; Achouh L; Lefrère F; Le Pavec J; Marfaing-Koka A; Dartevelle P; Simonneau G; Humbert M; Hermine O
Respiration; 2008; 76(3):295-302. PubMed ID: 18160817
[TBL] [Abstract][Full Text] [Related]
17. [Choice of therapy and overall survival in patients with chronic myeloproliferative diseases].
Rukavitsyn OA; Pop VP; Seriakov AP
Vopr Onkol; 2004; 50(4):435-9. PubMed ID: 15605767
[TBL] [Abstract][Full Text] [Related]
18. A myeloproliferative disorder may hide another one.
Laibe S; Tadrist Z; Arnoulet C; Sainty D; Mozziconacci MJ
Leuk Res; 2009 Aug; 33(8):1133-6. PubMed ID: 19250672
[TBL] [Abstract][Full Text] [Related]
19. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification.
Kvasnicka HM; Thiele J
Pathobiology; 2007; 74(2):63-71. PubMed ID: 17587877
[TBL] [Abstract][Full Text] [Related]
20. Essential thrombocythemia and pregnancy.
Valera MC; Parant O; Vayssiere C; Arnal JF; Payrastre B
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):141-7. PubMed ID: 21640467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
